Securing Drug Supply: Boosting US Manufacturing and Transparency.
This Act aims to secure the supply of critical medicines in the US by reducing reliance on foreign manufacturers. It mandates the creation of a list of drugs essential for public health and national security and authorizes $5 billion for contracts with US companies to build domestic capacity for manufacturing drug ingredients. Citizens can expect greater stability in access to necessary medications and increased price transparency for drugs produced under these contracts.
Key points
A confidential list of drugs critical to public health and national security will be created to focus production efforts.
$5 billion is authorized for contracts with US companies to increase domestic manufacturing of critical drug ingredients, reducing import dependency.
Contracted companies must maintain drug reserves and commit to selling products at public, "fair and reasonable prices," protecting patients from excessive costs.
Starting in 2029, federal agencies must prioritize purchasing critical drugs wholly manufactured in the United States.
Status:
Expired
Civic Will
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.